168 related articles for article (PubMed ID: 29158770)
1. Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?
Drygalski K; Berk K; Charytoniuk T; Iłowska N; Łukaszuk B; Chabowski A; Konstantynowicz-Nowicka K
Nutr Metab (Lond); 2017; 14():69. PubMed ID: 29158770
[TBL] [Abstract][Full Text] [Related]
2. The effect of enterolactone on liver lipid precursors of inflammation.
Berk K; Drygalski K; Harasim-Symbor E; Charytoniuk T; Iłowska N; Łukaszuk B; Chabowski A; Konstantynowicz-Nowicka K
Life Sci; 2019 Mar; 221():341-347. PubMed ID: 30802511
[TBL] [Abstract][Full Text] [Related]
3. The effect of enterolactone on sphingolipid pathway and hepatic insulin resistance development in HepG2 cells.
Charytoniuk T; Iłowska N; Berk K; Drygalski K; Chabowski A; Konstantynowicz-Nowicka K
Life Sci; 2019 Jan; 217():1-7. PubMed ID: 30468835
[TBL] [Abstract][Full Text] [Related]
4. Effect of pre-existing maternal obesity, gestational diabetes and adipokines on the expression of genes involved in lipid metabolism in adipose tissue.
Lappas M
Metabolism; 2014 Feb; 63(2):250-62. PubMed ID: 24262292
[TBL] [Abstract][Full Text] [Related]
5. Isosilybin regulates lipogenesis and fatty acid oxidation via the AMPK/SREBP-1c/PPARα pathway.
Liu X; Hu M; Ye C; Liao L; Ding C; Sun L; Liang J; Chen Y
Chem Biol Interact; 2022 Dec; 368():110250. PubMed ID: 36347319
[TBL] [Abstract][Full Text] [Related]
6. Prolactin improves hepatic steatosis via CD36 pathway.
Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
[TBL] [Abstract][Full Text] [Related]
7. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
8. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
9. Effects of hyperthyroidism on lipid content and composition in oxidative and glycolytic muscles in rats.
Miklosz A; Chabowski A; Zendzian-Piotrowska M; Gorski J
J Physiol Pharmacol; 2012 Aug; 63(4):403-10. PubMed ID: 23070090
[TBL] [Abstract][Full Text] [Related]
10. Water Extract of
Mun J; Kim S; Yoon HG; You Y; Kim OK; Choi KC; Lee YH; Lee J; Park J; Jun W
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640183
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis.
Yang F; Wu Y; Chen Y; Xi J; Chu Y; Jin J; Yan Y
JHEP Rep; 2023 Jul; 5(7):100746. PubMed ID: 37274776
[TBL] [Abstract][Full Text] [Related]
12. Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis.
Zhang H; Li Y; Hu J; Shen WJ; Singh M; Hou X; Bittner A; Bittner S; Cortez Y; Tabassum J; Kraemer FB; Azhar S
PLoS One; 2015; 10(9):e0138203. PubMed ID: 26394137
[TBL] [Abstract][Full Text] [Related]
13. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
[TBL] [Abstract][Full Text] [Related]
14. Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway.
Chen S; Sun S; Feng Y; Li X; Yin G; Liang P; Yu W; Meng D; Zhang X; Liu H; Zhang F
Eur J Pharmacol; 2023 Aug; 952():175808. PubMed ID: 37263401
[TBL] [Abstract][Full Text] [Related]
15. Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.
Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Porras JA; Aragonès G; Sabench F; Hernandez M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2014 Dec; 15(12):22173-87. PubMed ID: 25474087
[TBL] [Abstract][Full Text] [Related]
16. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells.
Fang K; Wu F; Chen G; Dong H; Li J; Zhao Y; Xu L; Zou X; Lu F
BMC Complement Altern Med; 2019 Sep; 19(1):255. PubMed ID: 31519174
[TBL] [Abstract][Full Text] [Related]
17. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
Serviddio G; Bellanti F; Vendemiale G
Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
[TBL] [Abstract][Full Text] [Related]
18. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
19. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment of hydroethanolic extract of Dillenia indica L. attenuates oleic acid induced NAFLD in HepG2 cells via modulating SIRT-1/p-LKB-1/AMPK, HMGCR & PPAR-α signaling pathways.
Poornima MS; Sindhu G; Billu A; Sruthi CR; Nisha P; Gogoi P; Baishya G; G Raghu K
J Ethnopharmacol; 2022 Jun; 292():115237. PubMed ID: 35351574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
